Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Furosemide is dosed at 2–4 mg/kg IM q6-8h in dogs, per Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127-1140. doi:10.1111/jvim.15488 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.592 (2026-08-01). — Plumb's 10th ed (held) printed p.563, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207. Furosemide is used in dogs for CHF when IV not available, Oliguric renal failure (to promote urine production), Acute CHF, pulmonary edema (emergency), Adjunctive treatment of congestive heart failure (oral maintenance, stage C myxomatous mitral valve disease). Routes documented in dogs: IM, IV, PO, SC. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 7 cited dose rules for Furosemide in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Lasix, Salix
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| IM | 2–4 mg/kg |
| q6-8h |
| Until IV access or oral feasible |
| CHF when IV not available |
| Strong |
| Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127-1140. doi:10.1111/jvim.15488 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.592 (2026-08-01). — Plumb's 10th ed (held) printed p.563, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| IV | 2–6 mg/kg | q6-8h | 48-72 hours trial | Oliguric renal failure (to promote urine production) | Moderate | Plumb's Veterinary Drug Handbook, 10th ed (2023, held copy; the original seed cited the 9th, which was never consulted) — Plumb's 10th ed (held) printed p.563, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| IV | 2–4 mg/kg | q1-4h | Emergency until stabilized | Acute CHF, pulmonary edema (emergency) | Strong | Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127-1140. doi:10.1111/jvim.15488; DeFrancesco TC. Management of cardiac emergencies in small animals. Vet Clin North Am Small Anim Pract. 2013;43(4):817-842. doi:10.1016/j.cvsm.2013.03.012 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.592 (2026-08-01). — Plumb's 10th ed (held) printed p.563, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| PO | 1–2 mg/kg | q12h | Chronic with monitoring | Adjunctive treatment of congestive heart failure (oral maintenance, stage C myxomatous mitral valve disease) | Moderate | Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127-1140. doi:10.1111/jvim.15488 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.593 (2026-08-01). — Plumb's 10th ed (held) printed p.563, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| PO | 2–4 mg/kg | q8-12h | Chronic; use lowest effective dose | Cardiogenic pulmonary edema (chronic management) | Strong | Chew D, Schenck P, Jaeger J. Assessment and treatment of clinical cases with elusive disorders of hypercalcemia. Presented at: ACVIM Forum; 2003. — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.593 (2026-08-01). — Plumb's 10th ed (held) printed p.563, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| PO | 1–4 mg/kg | q8-12h | Chronic; lowest effective dose | CHF, pulmonary edema, ascites | Strong | BSAVA Small Animal Formulary, 10th ed, Part A — Canine and Feline, Furosemide, DOSES, Dogs/Cats, printed p.177: "Chronic, congestive heart failure: 1-5 mg/kg p.o. q6-12h. Typical maintenance doses for mild to […]" Corroborated in Plumb's Veterinary Drug Handbook, 10th ed (held), Furosemide, DOGS, "Adjunctive treatment of CHF (oral administration)", printed p.566 (corpus PDF p.593). [CITATION CORRECTED 2026-08-12 — the supporting page previously recorded for this figure, Quesenberry & Carpenter printed p.59, is a FERRET heart-failure row, not a canine one.] — SOURCE EDITIONS: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207; BSAVA Small Animal Formulary, Part A — ISBN 9781910443705, https://openlibrary.org/isbn/9781910443705 |
| SC | 1–4 mg/kg | q8-12h | As needed | CHF maintenance when oral difficult | Moderate | Chew D, Schenck P, Jaeger J. Assessment and treatment of clinical cases with elusive disorders of hypercalcemia. Presented at: ACVIM Forum; 2003. — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.593 (2026-08-01). — Plumb's 10th ed (held) printed p.565, Furosemide monograph spanning p.563-567; page located 2026-08-05 from the book's own running heads, and carries this exact dose under the matching species heading. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
The sources disagree for this combination. The ranges below do not overlap on a comparable route. This is not an error in one of them — published veterinary references differ, and reconciling them for a particular patient is a clinical judgement.
| Dose (%) | Route | Source | As printed |
|---|---|---|---|
| 5 | IV | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | natively, a dose of 2 mg/kg in 5% glucose can be infused over an 8 hour period IV. |
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 1–5 | PO | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.193 | l effusion present. • Chronic, congestive heart failure: 1-5 mg/kg p.o. q6-12h. Typical maintenance doses for mild to moderate CHF are 1-2 mg/kg p |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Inhibits sodium-potassium-chloride cotransporter (NKCC2) in the thick ascending limb of the loop of Henle, producing potent diuresis.
Monitor electrolytes (hypokalemia, hyponatremia). Ototoxicity at high IV doses. Dehydration risk. May worsen renal azotemia. Adjust dose based on clinical response.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Furosemide dose ranges in dogs, with cited source references: IM 2–4 mg/kg q6-8h; IV 2–6 mg/kg q6-8h; IV 2–4 mg/kg q1-4h; PO 1–2 mg/kg q12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Furosemide in dogs: IM, IV, PO, SC.
Cited course lengths for Furosemide in dogs include: Until IV access or oral feasible; 48-72 hours trial; Emergency until stabilized; Chronic with monitoring. Duration depends on the indication — match it to the specific dose rule in the table above.
Furosemide is indicated in dogs for: CHF when IV not available, Oliguric renal failure (to promote urine production), Acute CHF, pulmonary edema (emergency), Adjunctive treatment of congestive heart failure (oral maintenance, stage C myxomatous mitral valve disease), Cardiogenic pulmonary edema (chronic management), CHF, pulmonary edema, ascites, CHF maintenance when oral difficult.
These are general warnings for Furosemide across species; consult the dog dosing table above for species-specific guidance. Monitor electrolytes (hypokalemia, hyponatremia). Ototoxicity at high IV doses. Dehydration risk. May worsen renal azotemia. Adjust dose based on clinical response.
Why a species-specific page? Furosemide pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.
| 1–2 |
| PO |
| BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.193 |
| d to moderate CHF are 1-2 mg/kg p.o. q8-24h (dogs) and 1-2 mg/kg p.o. q12-48h (cats). The goal is to use the lowest dose of furosemide that effective |
| 2–4 | IV | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.193 | g/kg i.v. If no diuresis within 1 hour, repeat dose at 2-4 mg/kg i.v. If no response within 1 hour give another dose at 2-4 mg/kg i.v. Alternatively |
| 2 | IV | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.193 | ly monitor fluid input and output. Give furosemide at 2 mg/kg i.v. If no diuresis within 1 hour, repeat dose at 2-4 mg/kg i.v. If no response with |
| 1–2 | IV | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.193 | • Acute, life-threatening congestive heart failure: 1-2 mg/kg i.v., i.m. q0.5-4h as required, based on improvement in respiratory rate and ef |
| 2 | PO | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | when treating heart failure patients is 2 mg/kg q12h PO, then lower to 1-2 mg/kg |
| 1–2 | PO | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | when treating heart failure patients is 2 mg/kg q12h PO, then lower to 1-2 mg/kg |
| 2 | IV | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | natively, a dose of 2 mg/kg in 5% glucose can be infused over an 8 hour period IV. |
| 2 | — | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | followed by 2 mg/kg every 30 minutes, until improvement is seen. |
| 0.66 | IV | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | • CRI: 0.66 mg/kg bolus dose IV, followed by 0.66 mg/kg/hr for 8 hours. Alter- |
| 2–6 | IV | Papich Saunders Handbook of Veterinary Drugs, 4th edp.376 | • 2-6 mg/kg q8-12h (or as needed) IV, IM, SQ, or PO. A common initial dose |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.